Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Chinese PLA General Hospital
Acute Kidney Injury
China
- A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)Active Not Recruiting
Sponsor: H. Lundbeck A/S
Multiple System Atrophy
United States, Australia, Canada, France, Germany +5 more
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
Brazil, Czechia, Hungary, India, Japan +9 more
- Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)Active Not Recruiting
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Immunoglobulin A Nephropathy
United States, Argentina, Australia, Belgium, Brazil +26 more
Sponsor: Ming-an Yu
Papillary Thyroid Carcinoma
China
- A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CMActive Not Recruiting
Sponsor: AstraZeneca
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
United States, Canada, China, France, Germany +5 more
- Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney DiseaseRecruiting
Sponsor: Chinese PLA General Hospital
Diabetic Kidney Disease (DKD)
China
- Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial CancerActive Not Recruiting
Sponsor: AstraZeneca
Urothelial Cancer
United States, Australia, Austria, Belgium, Brazil +19 more
Sponsor: AstraZeneca
Type 2 Diabetes Mellitus
United States, Argentina, Australia, Brazil, Bulgaria +10 more
Sponsor: Astellas Pharma Global Development, Inc.
Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
United States, Australia, Belgium, Canada, France +8 more
- Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and AboveActive Not Recruiting
Sponsor: GlaxoSmithKline
Respiratory Syncytial Virus Infections
United States, Finland, Germany, Japan, Taiwan
- Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)Active Not Recruiting
Sponsor: EMD Serono Research & Development Institute, Inc.
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification · Lung Adenocarcinoma Stage IIIB/IV
United States, Austria, Belgium, China, France +10 more
- Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)Active Not Recruiting
Sponsor: AstraZeneca
ER-Positive HER2-Negative Breast Cancer
United States, Australia, Austria, Belgium, Bulgaria +18 more
Sponsor: AstraZeneca
Advanced or Metastatic Non-Small Cell Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +18 more
- Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDPEnrolling By Invitation
Sponsor: Sanofi
Polyneuropathy, Inflammatory Demyelinating, Chronic
United States, Argentina, Brazil, Canada, Chile +16 more
- Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3Active Not Recruiting
Sponsor: Sanofi
Gaucher's Disease Type III
United States, Argentina, Canada, China, France +6 more
- Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCCActive Not Recruiting
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, Belgium, Brazil, Canada, China +17 more
- Fabhalta Capsules Specified Drug-use SurveyActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
C3 Glomerulopathy
Japan
Sponsor: Merck Sharp & Dohme LLC
Malignant Neoplasm · Carcinoma, Merkel Cell · Lymphoma
Japan
Sponsor: China-Japan Friendship Hospital
Depth of Anesthesia Monitoring · BIS-EEG
China
Sponsor: AstraZeneca
Advanced Solid Tumors That Are MTAP Deficient
United States, Australia, China, France, Japan +3 more
Sponsor: Novartis Pharmaceuticals
C3G
United States, Argentina, Belgium, Brazil, Canada +14 more
Sponsor: Novartis Pharmaceuticals
IC-MPGN
United States, Argentina, Brazil, Canada, Czechia +18 more
- Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKDNot Yet Recruiting
Sponsor: Chen Xiangmei
Diabetic Nephropathy
China
Sponsor: Anthos Therapeutics, Inc.
Atrial Fibrillation (AF)
United States, Argentina, Brazil, Bulgaria, Canada +30 more